Market Cap: $93.16M
IC
ImmuCell Corporation
ICCC
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $93.16M
ImmuCell, a biotechnology company focused on animal health, announces its preliminary revenue results for the first quarter of 2026, revealing a robust growth trajectory. With revenues reaching $10.4…
Emerging Trends in Retail Sales Impact Animal Health Strategies Earnings season casts a spotlight on consumer behavior and market trends, and as major retailers prepare to report their quarterly resul…
Understanding Retail Dynamics Amid Economic Pressures In the current economic landscape, the retail sector experiences heightened scrutiny as major players report their quarterly earnings. Companies l…
Immucell Stands at the Intersection of Animal Health Innovation Amid Market Volatility Immucell continues to establish itself as a pivotal player in the animal health sector, particularly with its foc…
ImmuCell Faces Regulatory Hurdle for Re-Tain Approval Animal health company ImmuCell Corporation is currently navigating a significant regulatory challenge following the receipt of an Incomplete Lette…
Immucell's Strategic Position in Veterinary Pharmaceuticals Amid Market Developments In the evolving landscape of veterinary pharmaceuticals, Immucell stands out with its innovative approach to animal…
Immucell's Strategic Positioning in Animal Health Immucell, a company dedicated to improving the health and well-being of livestock through innovative biological products, continues to enhance its str…